Shasun Pharmaceuticals lost 3.24% to Rs 149.50 at 10:53 IST on BSE after the company reported consolidated net loss of Rs 4.80 crore in Q1 June 2014, lower than net loss of Rs 6.57 crore in Q1 June 2013.
The Q1 result was announced after market hours on Wednesday, 6 August 2014.
Meanwhile, the S&P BSE Sensex was down 57.56 points or 0.22% at 25,607.71.
On BSE, so far 1.24 lakh shares were traded in the counter as against average daily volume of 2.01 lakh shares in the past two weeks.
The stock hit a high of Rs 154 and a low of Rs 146 so far during the day.
Shasun Pharmaceuticals (Shasun) attributed the loss in Q1 June 2014 mainly to phasing of orders in UK operations.
Shasun's consolidated gross revenue rose 38% to Rs 313.72 crore in Q1 June 2014 over Q1 June 2013. EBITDA after R&D cost rose 190.45% to Rs 21 crore in Q1 June 2014 over Q1 June 2013.
Shasun Pharmaceuticals is an integrated pharmaceutical company with locations in India, UK and USA.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app